
Latvia will seek an emergency meeting of the United Nations Security Council in response to Russia’s latest heavy attacks on Ukraine, Latvian Foreign Minister Baiba Braže said on Friday.
Russia earlier carried out renewed large-scale airstrikes on Ukraine and said it had, for the second time since the start of the war, used its nuclear-capable Oreshnik intermediate-range missile in stike on the western city of Lviv, not far from the border with Poland.
"Latvia will request an extraordinary meeting of the UN Security Council in response to Russia’s barbaric attack against Ukraine, including using an intermediate range ballistic missile close to the EU and NATO border," Braže wrong on X.
Latvia took up a non-permanent seat on the Security Council for the first time on January 1 and will serve on the UN’s most powerful body for two years.
The Baltic EU and NATO member, which borders Russia, is a close partner and supporter of Ukraine, which has been fighting a Russian invasion for nearly four years.
LATEST POSTS
- 1
Tear gas and arrests: Iranian regime continues crackdown on protesters amid economic unrest - 2
Unwinding History's Secrets: Looking for the Response to Antiquated Human advancements - 3
OECD: Iran war dampening global growth - 4
Day to day Temporary Positions That Compensate Fairly in the US - 5
The most effective method to Engage in Local area Making arrangements for 5G Pinnacle Establishments
The Best Computer games for Multiplayer Fun
Arctic sea ice hits lowest winter level as unprecedented heat hits smashes records all over Earth
Disney's latest short film 'Versa' tackles a difficult subject: Pregnancy loss. It's resonating with viewers.
Cathay Pacific raises fuel surcharge on all flights by 34%
'Hero' who wrestled gun from Bondi shooter named as Ahmed al Ahmed
Netanyahu vows to ‘return Negev to Israel,’ pledges settlement growth during visit
Figure out How to Utilize Your Web based Advertising Degree to Break into the Tech Business
Rick Steves Doesn't Want You Overlooking This Food Spot While In France
Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer













